Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on March 24, 2026.
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fischer Medical Ventures' Board of Directors, at a meeting held on March 24, 2026 (11:10 AM to 12:20 PM), approved the appointment of Mr. Balaji Gandla as the Company's Secretary and Compliance Officer, effective the same day. Mr. Balaji will also serve as Company Secretary of the company's wholly owned subsidiary, M/s. Time Medical International Ventures (India) Private Limited. He is a qualified Company Secretary and Associate Member of ICSI, with a Bachelor of Commerce from the University of Madras and over a decade of experience in corporate governance, secretarial compliance, and regulatory affairs. The disclosure was made under SEBI LODR Regulations to keep the exchanges informed of a Key Managerial Personnel change.
This is a routine corporate governance and compliance-related appointment with no direct bearing on business operations, financials, or shareholder value. Shareholders are unlikely to see any meaningful stock price reaction to this news.